中文

Jiangsu Chengxing Phosph-Chemical Co., Ltd. (600078) · A-shares · phosphorus chemical

Report date: 2026-10-01 | Price data: 2026-09-30 close | Sources: 27 | Report engine: v2 (latest)
View PDF Download Word Download Markdown

Latest market data

Close8.53 (-1.5% on the day; -11.42% over 5 sessions; -6.78% over 20 sessions)
Market capCNY 5.80 billion
P/E (TTM)23.64x (65th percentile over 5.2 years)
P/B (MRQ)2.97x (41th percentile over 5.2 years)
P/S (TTM)1.28x (28th percentile over 5.2 years)
52-week range8.28 (2026-07-21) – 16.88 (2026-05-18)
Moving averagesMA5 8.85 / MA10 9.12 / MA20 9.05 / MA60 9.87
MACD (12,26,9)DIF -0.204, DEA -0.177, histogram -0.053
RSIRSI6 28.4 / RSI14 37.7
Bollinger bands (20,2)Upper 9.7 / middle 9.05 / lower 8.4
Volume0.48x the 20-day average
One-week range (about 68% coverage)8.04 – 9.1 (-5.7% ~ +6.7%)
One-week range (about 95% coverage)7.59 – 10.39 (-11.0% ~ +21.8%)

As of the 2026-11-18 close; calculated from daily price data (adjusted prices) and refreshed automatically each trading day. The one-week range reflects historical volatility only and is not a forecast. The report below was written on 2026-10-01; its prices and short-term scenarios reflect data at that time.

Jiangsu Chengxing Phosph-Chemical Co., Ltd. (600078)

Stock Analysis Report | Industry: Phosphorus Chemical | Report Date: October 1, 2026 | Market and Technical Indicators as of the Close on September 30, 2026

This report is automatically compiled and generated by AI based on public information, for reference only, and does not constitute investment advice.

Core Conclusion: Profitability has rebounded from the trough, but whether the recovery can be sustained remains to be verified, and the valuation already demands relatively high growth

Key DataValue
Closing Price (Daily Change)RMB 9.79 (+0.1%)
Total Market CapApprox. RMB 6.654 billion
PE(TTM)61.87x
PB(MRQ)3.7x
52-Week RangeRMB 6.21–16.88
Turnover / Turnover RateRMB 47.513 million / 0.73%

Market data as of: Market and technical indicators as of the close on September 30, 2026

1. Key Investment Points

  • Profitability has significantly recovered from the cyclical trough: H1 2026 revenue was RMB 2.138 billion, up 20.37% YoY; net profit attributable to parent was RMB 117.63 million, up 533.75% YoY; non-recurring profit turned from loss to profit, but the YoY growth rate is affected by a low base.
  • The recovery still depends on prices, and idle capacity remains to be realized: H1 gross margin rose to 19.09%, driven by yellow phosphorus and phosphoric acid prices and cost control; phosphoric acid capacity utilization was only 46.42%, and phosphate salts only 14.53%.
  • The stock price corresponds to a high PE, and the valuation demands are relatively high: Closing price on September 30 was RMB 9.79, PE-TTM 61.87x, PB 3.7x; there is no verifiable consensus estimate or target price, making direct comparison with forward PE difficult.

Market Expectations and Evidence

  • The market is pricing in: The 61.87x PE implies an average annual EPS growth of approximately 24.4% over the next 10 years (assuming an 8% annualized return and a terminal PE of 15x); there is no verifiable consensus estimate, so it cannot be determined whether the requirement is above or below institutional expectations.
  • Evidence shows: H1 revenue grew 20.37% and gross margin rose to 19.09%, confirming the earnings recovery; however, the improvement is mainly driven by product prices and costs, and the full-year sustainability, conversion of low-utilization capacity, and the 24.4% long-term growth requirement remain to be verified.

Evidence leaning: Balanced; Confidence: Medium

The H1 earnings and gross margin improvement is clear, but the main drivers are cyclical, and full-year performance and institutional consensus estimates are not yet verifiable.

2. Business and Competitiveness

2.1 Business Structure

The company produces and sells phosphorus chemical products such as yellow phosphorus, phosphoric acid, and phosphate salts. Revenue mainly comes from yellow phosphorus and phosphoric acid, and profitability is affected by product prices and raw material and energy costs.

Business SegmentRevenue ShareGross MarginRevenue GrowthKey Points
Yellow Phosphorus48.9% (2025 main business revenue)17.15% (2025)6.40% (2025 YoY)Capacity utilization 94.75%, output 151,600 tons.
Phosphoric Acid45.8% (2025 main business revenue)5.25% (2025)13.86% (2025 YoY)Capacity utilization 46.42%, nominal capacity not fully converted into effective supply.
Phosphate Salts3.0% (2025 main business revenue)11.21% (2025)-29.72% (2025 YoY)Capacity utilization 14.53%, completion time of relocation project uncertain.
Other Chemical Products2.3% (2025 main business revenue)25.29% (2025)27.84% (2025 YoY)Revenue scale is relatively small.

2.2 Competitive Advantages

Competitive Advantage Strength: Weak

  • Some self-owned phosphate mines and supporting hydropower and thermal power; mines mainly meet self-use, self-sufficiency rate not disclosed.
  • Yellow phosphorus designed capacity of 160,000 tons/year, 2025 output of 151,600 tons, utilization rate 94.75%.
  • Disclosed products such as food-grade and electronic-grade phosphoric acid and long-term customer cooperation, but customer-side certification and premium not quantified.

Main threats: Fluctuations in yellow phosphorus and phosphoric acid prices and ore and energy costs; low utilization of phosphoric acid and phosphate salts, plus safety, environmental, and relocation risks.

2.3 Industry Chain Position and Profit Trend

  • Main inputs include phosphate rock, coke breeze, electrodes, thermal coal, and electricity; phosphoric acid uses yellow phosphorus as raw material, and phosphate salts also use phosphoric acid, soda ash, and calcium carbonate.
  • In 2025, direct materials accounted for 91.29% of chemical main business costs; phosphate rock procurement price rose 10.43% YoY, coke breeze fell 20.55%, electricity fell 6.20%. The company has some self-owned mines and electricity but still needs external procurement, with limited pricing power over inputs.
  • Products are used in thermal phosphoric acid and chemical intermediates, food industry, daily chemicals, metal phosphating, and cathode materials; fine-grade products may create differentiation, but the premium is not quantified.
  • Yellow phosphorus and phosphoric acid are affected by market supply and demand and raw material costs, with limited product pricing influence; customer list and payment terms not disclosed, making it difficult to judge specific customer bargaining power.
  • The 2025 annual report disclosed that the top five customers accounted for 21.68% of sales, and the top five suppliers accounted for 32.94% of procurement; no independent cross-verification was seen, and specifics should be based on the latest annual report.
  • At end-2025, accounts receivable were approximately RMB 104 million, 2.90% of revenue and approximately 1.05x consolidated net profit; notes receivable were RMB 877 million, up 63.85% YoY; prepayments were RMB 22.2879 million, up 215.16% YoY; net operating cash flow was RMB 377 million.
Gross Margin / Net Margin-10.08%7.92%25.92%202220232024202521.77%9.78%6.94%11.82%11.50%-1.96%-5.93%0.24%Gross MarginNet Margin
Gross Margin / Net Margin
YearGross MarginNet MarginReason for Change
2022Approx. 21.77%Approx. 11.50% (attributable to parent)Phosphorus chemical industry boom, good product gross margin.
2023Approx. 9.78%Approx. -1.96% (attributable to parent)Product prices fell, phosphoric acid under pressure with inventory write-downs.
2024Approx. 6.94%Approx. -5.93% (attributable to parent)Weak demand, yellow phosphorus prices moved lower, phosphate rock costs at high levels.
2025Approx. 11.82%Approx. 0.24% (attributable to parent)Yellow phosphorus and phosphoric acid gross margin recovered, non-recurring losses persisted.

The company is positioned in the midstream phosphorus chemical segment, based on yellow phosphorus and extending to thermal phosphoric acid and phosphate salts, with profits affected by cyclical prices and input costs. Further improvement depends on raising phosphoric acid and phosphate salt utilization, stabilizing ore and energy costs, and verifying fine product premiums.

2.4 Industry and Peer Comparison

The phosphorus chemical industry is in cyclical fluctuation. In 2025, Chengxing's gross margin recovered but non-recurring profit remained at a loss; the key variables facing the company are the spread between product prices and raw material and energy costs, and whether low-utilization capacity can be converted into profit.

CompanyPositioningComparable DataDifference from This Company
Chuanjinnuo (300505)Phosphoric acid and phosphate salt products overlap with Chengxing.2025 revenue RMB 4.075 billion; company-wide gross margin approx. 18.0%; PE-TTM non-recurring 13.24x (September 18)Products are relatively close, but business structure differs; valuation date is not September 30.
Chuanheng Co., Ltd. (002895)Mining resources and phosphorus chemicals, feed-grade products.2025 revenue RMB 8.328 billion; phosphorus chemical gross margin 26.38%; PE-TTM approx. 14.32x (September 30)Higher proportion of mining resources and feed-grade products.
Xingfa Group (600141)Phosphate rock resources, diversified phosphorus chemical chain.2025 revenue RMB 29.300 billion; combined gross margin of the three main business categories approx. 18.0%; P/E 20.08x (September 30)Significantly larger scale, business covers mining, pesticides, new energy materials, etc.
Chuanfa Longmang (002312)Phosphate salts, fertilizers, and new energy materials.2025 revenue RMB 9.956 billion; gross margin —; PE-TTM non-recurring approx. 40.10x (September 18)Product chain leans more toward phosphate salts, fertilizers, and new energy materials.

Chengxing's yellow phosphorus scale and mine-power supporting facilities form a certain integration foundation, and its product structure is more concentrated in yellow phosphorus and thermal phosphoric acid than Chuanheng and Xingfa; however, self-owned mine coverage and fine product premiums are not quantified, and phosphoric acid and phosphate salt utilization are low. Peer resource endowments and business combinations differ significantly, so gross margins and valuations should not be directly compared horizontally.

3. Financial Quality

3.1 Operating Performance

Reporting PeriodRevenueYoYNet Profit Attributable to ParentYoYNon-Recurring YoYGross Margin
H1 2026RMB 2.138 billion20.37%RMB 117.63 million533.75%453.64% (loss to profit)19.09%
2025 AnnualRMB 3.596 billion7.16%RMB 8.47 million104.26% (loss to profit)75.29% (loss narrowed)11.8%
2024 AnnualRMB 3.356 billion8.22%RMB -198.90 million——6.94%

As of 2026-10-01; H1 2026 gross margin calculated based on revenue and cost.

H1 earnings recovered significantly, mainly driven by higher yellow phosphorus and phosphoric acid prices, increased phosphoric acid sales volume, and cost control; non-recurring profit turned from loss to profit, and the reported YoY 453.64% is affected by the negative base.

3.2 Financial Health Check

IndicatorValueAssessmentExplanation
Debt-to-Asset Ratio64.0% (mid-2026)WatchRelatively high debt ratio, current liabilities exceed current assets.
Current Ratio / Cash Ratio0.85/0.28 (mid-2026)WatchCurrent assets insufficient to cover current liabilities.
Operating Cash Flow / Net Profit Attributable to Parent1.92x (H1 2026)GoodOperating cash flow provides strong coverage of current-period profit.
Weighted Average ROE6.77% (H1 2026)AverageImproved from 1.11% in the same period last year, full-year sustainability to be verified.
Accounts Receivable Bad DebtRMB 23.6089 million (end-2025)WatchThere are amounts expected to be uncollectible and fully provided for.

4. Valuation and Market Expectations

4.1 Valuation Level

IndicatorCurrentOwn HistoryPeer Comparison
PE(TTM)61.87x69th percentile over past 5.2 years (median 12.06x)Approx. 9.53–20.88x, peer calculation methods differ
PB(MRQ)3.7x56th percentile over past 5.2 years (median 3.26x)Approx. 1.4–2.46x
PS(TTM)1.68x57th percentile over past 5.2 years (median 1.58x)—
Dividend Yield0%——

Valuation multiples calculated programmatically based on September 30, 2026 closing data (trailing twelve months basis)

Market-implied expectation: At the current 61.87x P/E, if investors require an 8% annualized return and a 15x P/E valuation after 10 years, EPS needs to grow approximately 24.4% annually (excluding dividends, relatively conservative), which can be compared with the consensus growth rate below.

PE-TTM of 61.87x is at the 69th percentile over the past 5.2 years, significantly above the historical median of 12.06x; PB of 3.7x is at the 56th percentile and PS of 1.68x at the 57th percentile, both slightly above their respective medians. The PE implies a requirement of approximately 24.4% average annual EPS growth, while institutional consensus estimates are missing; the current valuation already places relatively high demands on sustained earnings recovery.

4.3 Institutional Views

No verifiable target price; Tonghuashun has no ratings over the past 60 trading days, and the Sina page claims there are reports but does not show the institution, date, or rating.

5. Catalysts and Recent Events

5.1 Future Key Milestones

TimeEventKey Points
2026-10-28 (Q3 report scheduled disclosure)Q3 report disclosure and verification of operating continuityFocus on whether earnings can continue H1 growth, changes in product prices and raw material costs, and the impact after Xuzhou Hongda is consolidated; actual contribution has no public quantitative expectation.

5.2 Recent Important Events

  • 2026-08-18 Interim report net profit up 533.75% YoY (positive): H1 revenue RMB 2.138 billion, net profit attributable to parent RMB 117.6 million, up 20.37% and 533.75% YoY respectively; average prices of yellow phosphorus and phosphoric acid rose YoY, phosphate rock costs increased, and the report and operating data are unaudited.
  • 2026-09-30 Xuzhou Hongda completed industrial and commercial registration change (neutral): The company previously invested RMB 95.14 million to acquire a 45% equity interest in Xuzhou Hongda, which will be consolidated after the industrial and commercial registration change is completed; no quantifiable production, order, or profit contribution has been disclosed so far.
  • 2026-09-22 Relocation compensation receivable pledged and new guarantee added (neutral): The company used RMB 401.93 million of relocation compensation receivables to support a total of RMB 150 million in credit facilities; it also provided a guarantee for a subsidiary's RMB 80 million credit facility, assuming a maximum principal balance of RMB 44 million. The compensation payment is still pending completion of relocation acceptance and other procedures.

6. Bull-Bear Divergence and Risks

6.1 Bull Case

  • H1 2026 net profit attributable to parent was RMB 117.63 million, up 533.75% YoY, non-recurring profit turned around, and operating cash flow was 1.92x net profit.
  • Yellow phosphorus capacity utilization has reached 94.75%; if the spread between product prices and costs continues to improve, the H1 gross margin of 19.09% is expected to support earnings recovery.

6.2 Bear Case

  • PE-TTM of 61.87x is at the 69th percentile over the past 5.2 years, implying approximately 24.4% average annual EPS growth, higher than the currently disclosed revenue growth of 20.37%.
  • Phosphoric acid and phosphate salt utilization are only 46.42% and 14.53% respectively; phosphate salt revenue fell 29.72% YoY in 2025, and inefficient capacity has not yet formed a profit contribution.

6.3 Other Risks

  • Mid-2026 debt-to-asset ratio 64%, current ratio 0.85, cash ratio 0.28 → short-term debt repayment pressure may raise financial expenses and limit operating flexibility.
  • RMB 401.93 million relocation compensation receivable is still pending payment after acceptance and other procedures, and is used to support RMB 150 million in credit facilities → delayed collection may increase capital occupation and suppress cash flow.
  • End-2025 accounts receivable bad debt of RMB 23.6089 million has been fully provided for → if collection quality continues to deteriorate, new impairments will erode profits.

7. Tracking List

Tracking IndicatorCurrentBullish VerificationBearish Verification
Q3 report earnings continuityScheduled for disclosure on October 28, 2026Quarterly earnings continue and gross margin remains around 19%Quarterly profit declines significantly or gross margin falls below 15%
Phosphoric acid and phosphate salt utilization46.42% and 14.53% respectivelyBoth utilization rates continue to rise and drive segment profitability to turn positiveUtilization stagnates or declines, inefficient capacity continues to drag on profit
Operating cash flow and short-term debt repaymentH1 cash flow/net profit 1.92x; current ratio 0.85Operating cash flow continues to cover profit, current ratio rebounds above 1Cash flow weakens and current ratio declines further
Relocation compensation and Xuzhou Hongda contributionCompensation pending acceptance and payment; 45% equity in Xuzhou Hongda consolidatedCompensation received, or quantifiable production and profit contribution disclosedCollection continues to be delayed, no visible profit contribution after consolidation

8. Stock Price and Short-Term Outlook (Next Week, Scenario Projection, for Reference Only)

⚠️ ⚠️Risk Warning: The following are subjective heuristic scenario weights, not statistical probabilities, and do not constitute investment advice.****

8.1 Technical Overview

The stock price is below short- and medium-term moving averages, MACD remains negative, and the technical picture is weak; RSI6 is at a low level but has not confirmed a reversal. The full text of the September 30 outbound investment progress announcement has not been verified and is temporarily not included in the catalyst assessment.

IndicatorValueInterpretation
5/20-day Change-5.04%/-12.35%Recent decline is evident, short-term weak.
MA5/10/20/60MA5 9.85Stock price is below all moving averages, which form overhead resistance.
Bollinger Upper/Middle/Lower BandsUpper 11.37 / Middle 10.4 / Lower 9.44Close to the lower band, rebound still needs to reclaim the middle band.
MACD DIF/DEA/HistogramDIF -0.273 / DEA -0.202 / Histogram -0.142Histogram narrowed from the previous day but remains negative, reversal not confirmed.
RSI6/RSI14RSI6 29.3 / RSI14 36.7Short-cycle at a relatively low level, temporarily insufficient to confirm a bottom.

8.2 Key Price Levels

LevelRangeExplanation
Short-term ResistanceRMB 10.05–10.40Corresponds to MA10 and MA20/60; only after a valid hold can higher resistance zones be observed.
First SupportRMB 9.55–9.80Corresponds to the recent low of RMB 9.56 and near the closing price; if broken, watch the Bollinger lower band area.
Strong SupportRMB 9.40–9.56Corresponds to the Bollinger lower band of RMB 9.44 and the recent low; after a break, lower support needs to be assessed using longer-cycle structures.

8.3 One-Week Range Calculated by Historical Volatility

Using the September 30, 2026 price of RMB 9.79 as the baseline, the future 5-trading-day closing price range is projected using the return distribution over the past 300 trading days (scaled by the current index-weighted daily volatility of approximately 2.5%, retaining this stock's own frequency of large gains and losses):

Coverage ProbabilityPrice RangeRelative to Baseline
Approx. 68%RMB 9.31–10.43-4.9%–+6.5%
Approx. 95%RMB 8.9–11.57-9.1%–+18.2%

This range only reflects the stock's recent volatility magnitude and does not include a directional judgment; in the event of major announcements or a sharp market decline, actual movements may still exceed the range.

8.4 Next-Week Scenarios (Subjective Weights, Not Statistical Probabilities)

  • Consolidation (relatively high weight, approx. 50%): Holds RMB 9.55–9.80 without a volume-driven decline, market and sector do not weaken significantly, watch the RMB 9.44–10.40 range.
  • Weak downside (medium weight, approx. 30%): Breaks below RMB 9.40–9.56 on volume with continued capital outflow, may seek support in the RMB 9.00–9.40 range.
  • Rebound strength (relatively low weight, approx. 20%): After holding RMB 9.55–9.80, reclaims RMB 10.05–10.40 on volume, and the broader market or phosphorus chemical sector stabilizes, watch RMB 10.40–11.37.

8.5 Capital and Liquidity

As of September 30, 2026, turnover rate was 0.73% and turnover was RMB 47.513 million; recent daily turnover is estimated at approximately RMB 47 million–360 million. The June 30, 2026 interim report showed the top ten shareholders held approximately 44.51% in total, with the top two holding 40.92%; public funds and overseas institution/nominee accounts are visible, but individual holdings are relatively low, and the structure may have changed. Trading depth may weaken at low volumes, and larger orders may widen price impact and slippage.

If daily turnover reaches approximately RMB 200 million or more for two consecutive trading days and the price reclaims RMB 10.05–10.40, this can be viewed as a signal of improved capital participation.

The above scenario projection is based on September 30, 2026 closing data and historical price and technical indicator calculations. Short-term stock prices will also be affected by multiple factors such as news, capital flows, and the broader market environment. Technical indicators themselves have lag and limitations, do not guarantee actual future movements, and do not constitute buy or sell advice. Please combine the latest market information to make independent judgments and bear investment risks yourself.

Sources


This report was automatically retrieved, compiled, and generated by AI based on public channel information, with information as of market and technical indicators as of the close on September 30, 2026. There may be timeliness differences, and specific data should be based on the company's official announcements and authoritative data terminals. This report is only for information compilation and research reference, does not constitute any investment advice, and investors should make independent judgments and bear investment risks themselves.

Reports are generated by AI from public online information and may contain errors or outdated information. They are for research only, not investment advice. Verify material facts against company filings and authoritative sources.